Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Incontinence, Urge: later-stage trial registry

2 of 3 indexed Incontinence, Urge trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Incontinence, Urge: 3 US clinical trials tracked, 2 recruiting.

Incontinence, Urge is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Baylor Research Institute, running 1 of these trials.

Enrollment posture brief

Registry condition incontinence-urge

OPEN 2 | RECR 67% | LATE 3 | EARLY 0 | RANK #5209 | SPON 1

Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Incontinence, Urge (this)67%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Incontinence, Urge

Incontinence, Urge lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Incontinence, Urge on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Incontinence, Urge is recruiting above its size-band peers.

    2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 43

Phase Distribution

PhaseTrial count
Phase 4 3

Named interventions

Most-linked intervention names on Incontinence, Urge records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Rey Auditory Verbal Learning Test (RAVLT) Diagnostic test
1 trials
Functional magnetic resonance imaging (fMRI) Diagnostic test
1 trials
Beta-3 Agonists, Adrenergic Drug
1 trials
Anticholinergic Drug
1 trials
Tolterodine Tartrate ER Drug
1 trials
OnabotulinumtoxinA 100 UNT Drug
1 trials
Mirabegron Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Incontinence, Urge trials. A trial with sites in several states counts in each.

Texas 1 trials
Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Incontinence, Urge page

3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Incontinence, Urge condition card totals 3 registered trials; most-linked intervention Rey Auditory Verbal Learning Test (RAVLT); top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.